After John Ford received his lung cancer diagnosis, he worked with a team of physicians including cardiologists and oncologists to plan the best approach for his care. His lung cancer was treated with CyberKnife technology.

CyberKnife Radiation Therapy for Lung Cancer: Being diagnosed with lung cancer is terrifying, but it doesn’t have to be a death sentence any more.

Lung cancer is one of the most frequently treated diseases at the CyberKnife Center of Miami.

That’s because CyberKnife radiation therapy is becoming the number one treatment of choice by lung cancer patients.

Benefits of Non-Invasive Lung Cancer Treatment at CyberKnife

Excellent control of lung tumors due to precise radiation targeting

Lower risk of damage to healthy tissue surrounding tumors

Better quality of life for patients while undergoing treatment

With this cutting-edge technology, we can deliver very high doses of radiation to the tumor without damaging healthy or already compromised lung tissue.

It’s also the only technology that can continually track respiratory movement during treatment as the patient breathes, so radiation targets only the tumor, sparing normal lung tissue from being damaged. 

Treatments usually take 30 to 60 minutes and are done on an outpatient basis in three to five treatments. 

If the tumors come back, we can often ablate them again.

If you have lung cancer, it’s critical to understand your treatment options. 

To find out if you’re a candidate for life-saving CyberKnife radiosurgery, call the CyberKnife Miami at (800) 204-0455.

Our promise and commitment to our patients is to get you treated as effectively, safely and quickly as possible, with the least disruption to your life. 

We put patients first, that means we get you treated as quickly as possible. We hold your hand every step of the way. We answer the phone and return phone calls. We team up with you, your family and physicians to make the process as simple and easy as possible, because fighting cancer is tough enough. We’ll help ease that burden.